Free Trial
NYSEAMERICAN:AST

Asterias Biotherapeutics (AST) Stock Price, News & Analysis

Asterias Biotherapeutics logo
$0.0020 0.00 (0.00%)
As of 07/10/2019

About Asterias Biotherapeutics Stock (NYSEAMERICAN:AST)

Key Stats

Today's Range
$0.0020
$0.0020
50-Day Range
N/A
52-Week Range
$0.51
$2.05
Volume
1,000 shs
Average Volume
136,653 shs
Market Capitalization
$111.32 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asterias Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AST Stock News Headlines

ARTV Artiva Biotherapeutics, Inc.
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
CLDI Calidi Biotherapeutics, Inc.
Protalix BioTherapeutics Inc PLX
See More Headlines

AST Stock Analysis - Frequently Asked Questions

Asterias Biotherapeutics' stock was trading at $0.0020 on January 1st, 2025. Since then, AST shares have increased by 0.0% and is now trading at $0.0020.

Asterias Biotherapeutics Inc (NYSEAMERICAN:AST) announced its quarterly earnings data on Tuesday, March, 28th. The biotechnology company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.01. The biotechnology company earned $1.75 million during the quarter, compared to analyst estimates of $2.81 million.

Shares of AST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Asterias Biotherapeutics investors own include Zynerba Pharmaceuticals (ZYNE), CorMedix (CRMD), Synergy Pharmaceuticals (SGYP), 22nd Century Group (XXII), Amarin (AMRN), Gilead Sciences (GILD) and Progenics Pharmaceuticals (PGNX).

Company Calendar

Last Earnings
3/28/2017
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:AST
Previous Symbol
NYSEMKT:AST
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
55,659,000
Free Float
N/A
Market Cap
$111.32 thousand
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSEAMERICAN:AST) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners